Acquisition leverage Leverage Haemonetics acquisition to expand distribution channels and cross-sell ensoETM with broader perfusion and patient safety portfolios in hospitals and surgical centers.

Regulatory leadership Target hospitals and clinics seeking enhanced esophageal protection during ablation and other procedures, using the newly strengthened regulatory leadership from the VP of Regulatory Affairs to navigate procurement and compliance faster.

Strategic partnerships Capitalize on the Gentherm distribution agreement to bundle ensoETM with Blanketrol III heat exchangers, offering a combined temperature management solution to cardiac and electrophysiology clinics.

Phase growth Explore expansion into higher-revenue clinical settings with temperature management needs, such as cardiology labs and OR suites, where a closed-loop, user-friendly esophageal cooling device can reduce procedure risk and downtime.

Innovation signals Highlight ongoing product differentiation through FDA-cleared, single-system solution and integration with existing heat exchangers to appeal to procurement teams prioritizing safety, ease of use, and interoperability.